designed a melittin‐encapsulated hydrogel scaffold loading secretion of HOCl‐conditioned B16F10 cells (HOCl‐CDS hydrogel) to help B16F10 cell secretion release in tumor site.[231] These secretions, including TMVs, highly activated the type Ι IFN pathway and enhanced the expression of B7‐1/2. This evidence concerns the gene CD80 and neoplasm.